Advertisement
Singapore markets open in 7 hours 15 minutes
  • Straits Times Index

    3,272.72
    +47.55 (+1.47%)
     
  • S&P 500

    5,073.40
    +62.80 (+1.25%)
     
  • Dow

    38,549.61
    +309.63 (+0.81%)
     
  • Nasdaq

    15,701.53
    +250.22 (+1.62%)
     
  • Bitcoin USD

    66,786.38
    +3.69 (+0.01%)
     
  • CMC Crypto 200

    1,435.78
    +21.02 (+1.49%)
     
  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     
  • Gold

    2,339.40
    -7.00 (-0.30%)
     
  • Crude Oil

    83.09
    +1.19 (+1.45%)
     
  • 10-Yr Bond

    4.5900
    -0.0330 (-0.71%)
     
  • Nikkei

    37,552.16
    +113.55 (+0.30%)
     
  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     
  • FTSE Bursa Malaysia

    1,561.64
    +2.05 (+0.13%)
     
  • Jakarta Composite Index

    7,110.81
    +36.99 (+0.52%)
     
  • PSE Index

    6,506.80
    +62.72 (+0.97%)
     

How Teva Pharmaceutical Plans to Improve Financial Profile

How Teva Pharmaceutical Plans to Improve Financial Profile

Can Teva Pharmaceutical's Restructuring Plan Help It Recuperate? As we saw in the previous part of this series, Teva Pharmaceutical Industries (TEVA) is determined to pay down a considerable amount of its debt totaling $32 billion over the next few years. The company aims to achieve financial stability through improvement in operating profits and stable cash flow generation over the next few years.